Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 3/20 | 0.78 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.62 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.55 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.54 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.54 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.54 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.54 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11419154 | 0.96 | SRD5A2 (0.71) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| SCHEMBL200428 | 0.94 | SRD5A2 (0.88) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| SCHEMBL31202650 | 0.94 | PARP15 (0.69) | SRD5A2PARP10PARP15HSD17B10BCL2L1 | |
| SCHEMBL1888572 | 0.94 | SRD5A2 (0.88) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| SCHEMBL6892687 | 0.94 | SRD5A2 (0.88) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| SCHEMBL30307442 | 0.94 | PARP15 (0.69) | SRD5A2PARP10PARP15HSD17B10BCL2L1 | |
| SCHEMBL2748100 | 0.94 | PARP15 (0.69) | SRD5A2PARP10PARP15HSD17B10BCL2L1 | |
| Biphenyl SCHEMBL20561236 | 0.92 | SRD5A2 (0.71) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| Hydrochloric Acid SCHEMBL10520761 | 0.91 | SRD5A2 (0.84) | SRD5A2PARP10PARP15PKMAKR1C3 | |
| Ammonia Solution, Strong SCHEMBL18151747 | 0.91 | SRD5A2 (0.84) | SRD5A2PARP10PARP15PKMAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108762-A | Active ester resin with phosphorus and self-extinguishing characteristic structure, and preparation method and application thereof | 四川东材科技集团股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-08-05 | — | — | US | disclosed |
| CN-118108762-A | Active ester resin with phosphorus and self-extinguishing characteristic structure, and preparation method and application thereof | 四川东材科技集团股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11358924-B2 | Dissociation of a 1,4-bis (4-phenoxybenzoyl)benzene-lewis acid complex in an aqueous solution | ARKEMA FRANCE (FR) | 2022-06-14 | — | — | US | disclosed |
| EP-3523292-B1 | HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS | DONG A SOCIO HOLDINGS CO LTD (KR) | 2021-12-15 | — | — | EP | disclosed |
| US-20210371398-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS | DONG A SOCIO HOLDINGS CO LTD (KR) | 2021-12-02 | — | — | US | disclosed |
| US-20210363088-A1 | METHOD FOR MANUFACTURING 1,4-BIS (4-PHENOXYBENZOYL)BENZENE AT AN ELEVATED TEMPERATURE | ARKEMA FRANCE (FR) | 2021-11-25 | — | — | US | disclosed |
| US-20210155571-A1 | PURIFICATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE BY CENTRIFUGAL FILTRATION | ARKEMA FRANCE (FR) | 2021-05-27 | — | — | US | disclosed |
| US-10981852-B2 | Ripening of 1,4-bis (4-phenoxybenzoyl)benzene | ARKEMA FRANCE (FR) | 2021-04-20 | — | — | US | disclosed |
| US-10913730-B2 | Heteroaryl compounds and their use as Mer inhibitors | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2021-02-09 | — | — | US | disclosed |
| EP-0465048-B1 | Carboxylic acid ester compound, liquid crystal compound, liquid crystal composition, liquid crystal element and light modulation method | MITSUI PETROCHEMICAL IND (JP) | 1996-09-11 | — | — | EP | disclosed |
| EP-0368006-B1 | Copolymers containing polybenzoxazole polybenzothiazole and polybenzimidazole moieties | DOW CHEMICAL CO (US) | 1995-04-05 | — | — | EP | disclosed |
| US-5151489-A | Block copolymers for compression molding to form fibers, films and laminates | THE DOW CHEMICAL COMPANY (US) | 1992-09-29 | — | — | US | disclosed |
| US-5098985-A | Block copolymers for films, fibers, laminates or compression moldings | THE DOW CHEMICAL COMPANY (US) | 1992-03-24 | — | — | US | disclosed |
| US-5089568-A | Block polymers | THE DOW CHEMICAL COMPANY (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0392008-A4 | COPOLYMERS CONTAINING POLYBENZOXAZOLE, POLYBENZOTHIAZOLE AND POLYBENZIMIDAZOLE MOIETIES | — | 1991-09-04 | — | — | EP | disclosed |
| US-5030706-A | With acrylation reactive end groups | THE DOW CHEMICAL COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0392008-A1 | COPOLYMERS CONTAINING POLYBENZOXAZOLE, POLYBENZOTHIAZOLE AND POLYBENZIMIDAZOLE MOIETIES | THE DOW CHEMICAL COMPANY (US) | 1990-10-17 | — | — | EP | disclosed |
| EP-0368006-A2 | Copolymers containing polybenzoxazole polybenzothiazole and polybenzimidazole moieties | THE DOW CHEMICAL COMPANY (US) | 1990-05-16 | — | — | EP | disclosed |
| WO-1990003995-A1 | COPOLYMERS CONTAINING POLYBENZOXAZOLE, POLYBENZOTHIAZOLE AND POLYBENZIMIDAZOLE MOIETIES | THE DOW CHEMICAL COMPANY (US) | 1990-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913730-B2 | Heteroaryl compounds and their use as Mer inhibitors | MERTK, RET, ERBB4 | SRD5A2 2211/4885PARP10 2572/4885PARP15 3324/4885 |
| US-12378224-B2 | Heteroaryl compounds and their use as Mer inhibitors | MERTK, RET, ERBB2 | SRD5A2 1974/4885PARP10 3343/4885PARP15 4023/4885 |
| US-20210363088-A1 | METHOD FOR MANUFACTURING 1,4-BIS (4-PHENOXYBENZOYL)BENZENE AT AN ELEVATED TEMPERATURE | TERT, TLL2, TLL1 | SRD5A2 3693/4885PARP10 3121/4885PARP15 2334/4885 |
| US-20210371398-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS | MERTK, RET, ERBB2 | SRD5A2 1974/4885PARP10 3343/4885PARP15 4023/4885 |
| US-11358924-B2 | Dissociation of a 1,4-bis (4-phenoxybenzoyl)benzene-lewis acid complex in an aqueous solution | SSB, PBRM1, TLL2 | SRD5A2 3802/4885PARP10 4548/4885PARP15 4184/4885 |
| US-20210155571-A1 | PURIFICATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE BY CENTRIFUGAL FILTRATION | PBRM1, PSMB4, PSMC1 | SRD5A2 4039/4885PARP10 4507/4885PARP15 4100/4885 |
| US-10981852-B2 | Ripening of 1,4-bis (4-phenoxybenzoyl)benzene | PSMC4, PSMB4, PSMC6 | SRD5A2 4444/4885PARP10 3956/4885PARP15 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.